Fecal calprotectin concentration and clinical response to certolizumab pegol in patients with active Crohn's disease: results from PRECiSE 2: P-42.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles